Browse experiments

Examples: survivin siRNA, R9, TAT, GGACGAGGACGAGCACUUCTT

Download filtered results Clear

First Previous 1 ... 8 9 10 11 12 ... 26 Next Last

Page 10 of 26 (2582 experiments total, 100 per page)

Experiment Paper Year Peptide RNA type Uptake confirmed In vitro functional effect Endosomal escape evidence In vivo Success class
EXP000901 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect4 ASO yes yes no no
EXP000902 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect5 ASO yes yes no no
EXP000903 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect6 ASO yes yes no no
EXP000904 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect7 ASO yes yes no no
EXP000905 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect8 ASO yes yes no no
EXP000906 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect9 ASO yes yes no no
EXP000907 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mtCPP1 ASO yes yes no no
EXP000908 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mtCPP1 + PF14 ASO yes yes no no
EXP000909 Enhanced target cell specificity and uptake of lipid nanoparticles using RNA ap… 2021 T7 not reported no no no no
EXP000910 Enhanced target cell specificity and uptake of lipid nanoparticles using RNA ap… 2021 Tat not reported no no no no
EXP000911 Enhanced target cell specificity and uptake of lipid nanoparticles using RNA ap… 2021 T7 aptamer yes no no no
EXP000912 Enhanced target cell specificity and uptake of lipid nanoparticles using RNA ap… 2021 Tat aptamer yes no no no
EXP000913 Enhanced target cell specificity and uptake of lipid nanoparticles using RNA ap… 2021 T7 aptamer yes no no no
EXP000914 Enhanced target cell specificity and uptake of lipid nanoparticles using RNA ap… 2021 Tat aptamer yes no no no
EXP000915 Thiol-Cyanobenzothiazole Ligation for the Efficient Preparation of Peptide-PNA … 2019 ApoE(140-150) CPP – thiol–maleimide linkage (C3) ASO no yes no no
EXP000916 Thiol-Cyanobenzothiazole Ligation for the Efficient Preparation of Peptide-PNA … 2019 ApoE(140-150) CPP – thiol–CBT linkage (C4) ASO no yes no no
EXP000917 Intracellular delivery of nucleic acid by cell‐permeable hPP10 peptide 2018 hPP10 pDNA no yes no no
EXP000918 Intracellular delivery of nucleic acid by cell‐permeable hPP10 peptide 2018 hPP10 pDNA no yes no no
EXP000919 Intracellular delivery of nucleic acid by cell‐permeable hPP10 peptide 2018 hPP10 pDNA no yes no no
EXP000920 Intracellular delivery of nucleic acid by cell‐permeable hPP10 peptide 2018 hPP10 (with hPP10-NLS-Cre protein) pDNA no yes no no
EXP000921 Intracellular delivery of nucleic acid by cell‐permeable hPP10 peptide 2018 TAT pDNA no yes no no
EXP000922 Intracellular delivery of nucleic acid by cell‐permeable hPP10 peptide 2018 TAT pDNA no yes no no
EXP000923 Intracellular delivery of nucleic acid by cell‐permeable hPP10 peptide 2018 TAT pDNA no yes no no
EXP000924 Intracellular delivery of nucleic acid by cell‐permeable hPP10 peptide 2018 hPP10-E3 siRNA no yes no no
EXP000925 Intracellular delivery of nucleic acid by cell‐permeable hPP10 peptide 2018 hPP10-E3 siRNA no yes no no
EXP000926 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 PF6 SCO no yes no no
EXP000927 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 PF14 SCO no yes no no
EXP000928 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 PF6 SCO no yes no no
EXP000929 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 PF14 SCO no yes no no
EXP000930 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 St-RXR4 SCO no yes no no
EXP000931 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 Pal-RXR4 SCO no yes no no
EXP000932 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 St-RXR3 SCO no yes no no
EXP000933 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 STR4 SCO no yes no no
EXP000934 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 STR5 SCO no yes no no
EXP000935 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 St-KL4 SCO no yes no no
EXP000936 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 St-ST1 SCO no yes no no
EXP000937 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 Lau-RXR4 SCO no yes no no
EXP000938 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 PF14 SCO no yes no no
EXP000939 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 St-RXR4 SCO no yes no no
EXP000940 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 Pal-RXR4 SCO no yes no no
EXP000941 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 St-RXR3 SCO no yes no no
EXP000942 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 STR4 SCO no yes no no
EXP000943 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 STR5 SCO no yes no no
EXP000944 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 St-KL4 SCO no yes no no
EXP000945 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 St-ST1 SCO no yes no no
EXP000946 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 Ac-RXR4 SCO no yes no no
EXP000947 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 Myr-RXR4 SCO no yes no no
EXP000948 A one-pot modular assembly strategy for triple-play enhanced cytosolic siRNA de… 2019 Octreotide (N3-Oct) siRNA yes yes no no
EXP000949 A one-pot modular assembly strategy for triple-play enhanced cytosolic siRNA de… 2019 Tat(49–57) CPP (N3-CPP) siRNA yes yes no no
EXP000950 A one-pot modular assembly strategy for triple-play enhanced cytosolic siRNA de… 2019 Octreotide (N3-Oct) + Tat(49–57) CPP (N3-CPP) siRNA yes yes no no
EXP000951 A one-pot modular assembly strategy for triple-play enhanced cytosolic siRNA de… 2019 Octreotide (N3-Oct) + Tat(49–57) CPP (N3-CPP) (with Glu charge-reversal module) siRNA yes yes no no
EXP000952 A one-pot modular assembly strategy for triple-play enhanced cytosolic siRNA de… 2019 Octreotide (N3-Oct) + Tat(49–57) CPP (N3-CPP) siRNA no yes yes
EXP000953 A one-pot modular assembly strategy for triple-play enhanced cytosolic siRNA de… 2019 Octreotide (N3-Oct) + Tat(49–57) CPP (N3-CPP) (with Glu charge-reversal module) siRNA no yes yes
EXP000954 Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by pro… 2023 Pip9b2 anti-miRNA no yes yes no
EXP000955 Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by pro… 2023 Pip9b2 anti-miRNA no yes yes
EXP000956 Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by pro… 2023 Pip9b2KC anti-miRNA no yes yes no
EXP000957 Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by pro… 2023 Pip9b2KC anti-miRNA no yes yes
EXP000958 Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by pro… 2023 Pip6aKC anti-miRNA no yes yes no
EXP000959 Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by pro… 2023 Pip6aKC anti-miRNA no yes yes
EXP000960 Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by pro… 2023 Pip9b2 anti-miRNA no yes yes no
EXP000961 Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by pro… 2023 Pip9b2 anti-miRNA no yes yes
EXP000962 Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by pro… 2023 Pip9b2KC anti-miRNA no yes yes no
EXP000963 Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by pro… 2023 Pip9b2KC anti-miRNA no yes yes
EXP000964 Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by pro… 2023 Pip6aKC anti-miRNA no yes yes no
EXP000965 Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by pro… 2023 Pip6aKC anti-miRNA no yes yes
EXP000966 Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by pro… 2023 Pip9b2 anti-miRNA no no yes no
EXP000967 Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by pro… 2023 Pip9b2 anti-miRNA no yes no
EXP000968 Hydrophobic CPP/HDO conjugates: a new frontier in oligonucleotide-warheaded PRO… 2024 P4 RNA, unspecified yes yes no no no
EXP000969 Hydrophobic CPP/HDO conjugates: a new frontier in oligonucleotide-warheaded PRO… 2024 P4 oligonucleotide no yes no no
EXP000970 Hydrophobic CPP/HDO conjugates: a new frontier in oligonucleotide-warheaded PRO… 2024 P4 oligonucleotide no no no no
EXP000971 Cell-Penetrating Peptide-Mediated Delivery of Gene-Silencing Nucleic Acids to t… 2025 γ-zein-CADY siRNA yes yes yes
EXP000972 Cell-Penetrating Peptide-Mediated Delivery of Gene-Silencing Nucleic Acids to t… 2025 γ-zein-CADY siRNA yes yes no
EXP000973 Cell-Penetrating Peptide-Mediated Delivery of Gene-Silencing Nucleic Acids to t… 2025 γ-zein-CADY ASO no yes no
EXP000974 Cell-Penetrating Peptide-Mediated Delivery of Gene-Silencing Nucleic Acids to t… 2025 γ-zein-CADY ASO no yes no
EXP000975 Cell-Penetrating Peptide-Mediated Delivery of Gene-Silencing Nucleic Acids to t… 2025 γ-zein-CADY ASO no yes yes
EXP000976 Cell-Penetrating Peptide-Mediated Delivery of Gene-Silencing Nucleic Acids to t… 2025 γ-zein-CADY ASO no yes no
EXP000977 Cell-Penetrating Peptide-Mediated Delivery of Gene-Silencing Nucleic Acids to t… 2025 γ-zein-CADY ASO no yes no
EXP000978 Cell-Penetrating Peptide-Mediated Delivery of Gene-Silencing Nucleic Acids to t… 2025 γ-zein-CADY siRNA no yes no
EXP000979 Cell-Penetrating Peptide-Mediated Delivery of Gene-Silencing Nucleic Acids to t… 2025 γ-zein-CADY siRNA no yes no
EXP000980 Cell-Penetrating Peptide-Mediated Delivery of Gene-Silencing Nucleic Acids to t… 2025 γ-zein-CADY siRNA no yes no
EXP000981 Cell-Penetrating Peptide-Mediated Delivery of Gene-Silencing Nucleic Acids to t… 2025 γ-zein-CADY ASO no yes yes
EXP000982 Cell-Penetrating Peptide-Mediated Delivery of Gene-Silencing Nucleic Acids to t… 2025 CADY pDNA no yes no
EXP000983 Cell-Penetrating Peptide-Mediated Delivery of Gene-Silencing Nucleic Acids to t… 2025 γ-zein-CADY pDNA no yes no
EXP000984 Cell-Penetrating Peptide-Mediated Delivery of Gene-Silencing Nucleic Acids to t… 2025 γ-zein-CADY miRNA no yes no
EXP000985 Identifying Antisense Oligonucleotides to Disrupt Small RNA Regulated Antibioti… 2023 (KFF)3K ASO no no no no
EXP000986 Identifying Antisense Oligonucleotides to Disrupt Small RNA Regulated Antibioti… 2023 (KFF)3K ASO no yes no no
EXP000987 Identifying Antisense Oligonucleotides to Disrupt Small RNA Regulated Antibioti… 2023 (KFF)3K ASO no no no no
EXP000988 Identifying Antisense Oligonucleotides to Disrupt Small RNA Regulated Antibioti… 2023 (KFF)3K not reported no yes no no
EXP000989 Designing siRNA for silencing the human ERBB2 gene in cancer treatment: Evaluat… 2025 CPP-1 siRNA no no no no
EXP000990 Designing siRNA for silencing the human ERBB2 gene in cancer treatment: Evaluat… 2025 CPP-2 siRNA no no no no
EXP000991 Designing siRNA for silencing the human ERBB2 gene in cancer treatment: Evaluat… 2025 CPP-3 siRNA no no no no
EXP000992 Designing siRNA for silencing the human ERBB2 gene in cancer treatment: Evaluat… 2025 CPP-4 siRNA no no no no
EXP000993 Designing siRNA for silencing the human ERBB2 gene in cancer treatment: Evaluat… 2025 CPP-5 siRNA no no no no
EXP000994 Designing siRNA for silencing the human ERBB2 gene in cancer treatment: Evaluat… 2025 CPP-6 siRNA no no no no
EXP000995 Designing siRNA for silencing the human ERBB2 gene in cancer treatment: Evaluat… 2025 CPP-7 siRNA no no no no
EXP000996 Designing siRNA for silencing the human ERBB2 gene in cancer treatment: Evaluat… 2025 CPP-8 siRNA no no no no
EXP000997 Designing siRNA for silencing the human ERBB2 gene in cancer treatment: Evaluat… 2025 LMWP CPP set (CPP-1..CPP-8) siRNA no no no no
EXP000998 Hybridization-Sensitive Fluorescent Oligonucleotide Probe Conjugated with Cell-… 2017 TAT oligonucleotide yes no no no no
EXP000999 Hybridization-Sensitive Fluorescent Oligonucleotide Probe Conjugated with Cell-… 2017 cTAT oligonucleotide yes no no no no
EXP001000 RNA toehold switch-based reporter assay to assess bacterial uptake of antisense… 2025 KFF ASO no yes no no

First Previous 1 ... 8 9 10 11 12 ... 26 Next Last